Dissecting N-Glycosylation Dynamics in Chinese Hamster Ovary Cells Fed-batch Cultures using Time Course Omics Analyses.

Industrial Biotechnology Metabolomics Process Biotechnology Transcriptomics

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
22 Feb 2019
Historique:
received: 30 07 2018
revised: 19 11 2018
accepted: 03 01 2019
pubmed: 27 1 2019
medline: 27 1 2019
entrez: 26 1 2019
Statut: ppublish

Résumé

N-linked glycosylation affects the potency, safety, immunogenicity, and pharmacokinetic clearance of several therapeutic proteins including monoclonal antibodies. A robust control strategy is needed to dial in appropriate glycosylation profile during the course of cell culture processes accurately. However, N-glycosylation dynamics remains insufficiently understood owing to the lack of integrative analyses of factors that influence the dynamics, including sugar nucleotide donors, glycosyltransferases, and glycosidases. Here, an integrative approach involving multi-dimensional omics analyses was employed to dissect the temporal dynamics of glycoforms produced during fed-batch cultures of CHO cells. Several pathways including glycolysis, tricarboxylic citric acid cycle, and nucleotide biosynthesis exhibited temporal dynamics over the cell culture period. The steps involving galactose and sialic acid addition were determined as temporal bottlenecks. Our results show that galactose, and not manganese, is able to mitigate the temporal bottleneck, despite both being known effectors of galactosylation. Furthermore, sialylation is limited by the galactosylated precursors and autoregulation of cytidine monophosphate-sialic acid biosynthesis.

Identifiants

pubmed: 30682623
pii: S2589-0042(19)30006-9
doi: 10.1016/j.isci.2019.01.006
pmc: PMC6352710
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102-120

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Biotechnol Bioeng. 1998 Jun 20;58(6):642-8
pubmed: 10099302
Biotechnol Bioeng. 2000 Jun 20;68(6):637-46
pubmed: 10799988
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Biotechnol Bioeng. 2005 Dec 20;92(6):711-28
pubmed: 16247773
Bioinformatics. 2006 May 1;22(9):1096-102
pubmed: 16481333
Biotechnol Bioeng. 2006 Dec 5;95(5):946-60
pubmed: 16807922
PLoS One. 2007 Aug 08;2(8):e713
pubmed: 17684559
J Biol Chem. 2008 Jun 20;283(25):17298-313
pubmed: 18411279
Glycobiology. 2009 Nov;19(11):1163-75
pubmed: 19506293
J Biol Chem. 2010 Jul 2;285(27):20664-74
pubmed: 20427278
J Biol Chem. 1990 Sep 15;265(26):15731-7
pubmed: 2118531
Biochemistry. 2011 Oct 18;50(41):8914-25
pubmed: 21910480
Biotechnol Prog. 2011 Nov-Dec;27(6):1730-43
pubmed: 21956887
Adv Biochem Eng Biotechnol. 2012;127:165-85
pubmed: 21975953
Metab Eng. 2012 Mar;14(2):138-49
pubmed: 22244936
Glycobiology. 2012 Jul;22(7):880-96
pubmed: 22377912
Biotechnol Prog. 2012 May-Jun;28(3):608-22
pubmed: 22473974
Mol Aspects Med. 2013 Apr-Jun;34(2-3):590-600
pubmed: 23506892
Nat Rev Drug Discov. 2013 Apr;12(4):306-24
pubmed: 23535934
Nat Biotechnol. 2013 Aug;31(8):759-65
pubmed: 23873082
Int J Mol Sci. 2014 Mar 14;15(3):4492-522
pubmed: 24637934
PLoS One. 2014 Jun 09;9(6):e98756
pubmed: 24911170
J Biotechnol. 2014 Oct 20;188:88-96
pubmed: 25173615
Comput Struct Biotechnol J. 2014 Jun 11;10(16):23-32
pubmed: 25210595
Biotechnol Bioeng. 2015 Mar;112(3):521-35
pubmed: 25220616
FASEB J. 1989 Dec;3(14):2615-22
pubmed: 2531691
Biotechnol Bioeng. 2015 Jun;112(6):1165-76
pubmed: 25545631
J Autoimmun. 2015 Feb;57:1-13
pubmed: 25578468
J Pharm Sci. 2015 Mar;104(3):930-41
pubmed: 25583555
Biotechnol Prog. 2015 Mar-Apr;31(2):334-46
pubmed: 25641927
PLoS One. 2015 Mar 25;10(3):e0121561
pubmed: 25806512
PLoS Comput Biol. 2015 Jun 25;11(6):e1004310
pubmed: 26111374
Biotechnol J. 2015 Sep;10(9):1412-23
pubmed: 26212696
Trends Biotechnol. 2016 Oct;34(10):835-846
pubmed: 27016033
Biotechnol Prog. 2016 Sep;32(5):1123-1134
pubmed: 27254475
Trends Biotechnol. 2016 Aug;34(8):638-651
pubmed: 27265890
Biotechnol Prog. 2016 Sep;32(5):1135-1148
pubmed: 27273889
Curr Opin Struct Biol. 2016 Oct;40:97-103
pubmed: 27620650
Science. 2016 Oct 28;354(6311):
pubmed: 27789812
Sci Rep. 2016 Nov 22;6:36964
pubmed: 27872474
Cell Syst. 2017 Mar 22;4(3):318-329.e6
pubmed: 28215528
Sci Rep. 2017 Mar 02;7:43518
pubmed: 28252038
Sci Rep. 2017 Mar 10;7:44246
pubmed: 28281648
Metab Eng. 2017 Sep;43(Pt A):9-20
pubmed: 28754360
J Biotechnol. 2018 Apr 10;271:37-46
pubmed: 29476805
Biotechnol Bioeng. 2018 Aug;115(8):1890-1903
pubmed: 29603726
Biotechnol Prog. 1993 Jul-Aug;9(4):366-73
pubmed: 7763907
Biotechnology (N Y). 1995 Jul;13(7):692-8
pubmed: 9634806

Auteurs

Madhuresh Sumit (M)

Culture Process Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA.

Sepideh Dolatshahi (S)

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

An-Hsiang Adam Chu (AA)

Analytical Research and Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA.

Kaffa Cote (K)

Analytical Research and Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA.

John J Scarcelli (JJ)

Cell Line Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA.

Jeffrey K Marshall (JK)

Analytical Research and Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA.

Richard J Cornell (RJ)

Analytical Research and Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA.

Ron Weiss (R)

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Douglas A Lauffenburger (DA)

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Bhanu Chandra Mulukutla (BC)

Culture Process Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA. Electronic address: bhanuchandra.mulukutla@pfizer.com.

Bruno Figueroa (B)

Culture Process Development, Bio Therapeutics Pharmaceutical Sciences, Pfizer, 1 Burtt Road, Andover, MA 01810, USA.

Classifications MeSH